MEZZION PHARMA CO LTD has a total of 24 patent applications. It decreased the IP activity by 25.0%. Its first patent ever was published in 2015. It filed its patents most often in United States, Singapore and Taiwan. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are KNOBLER ROBERT L, PHOENIX MOLECULAR DESIGNS and KING CLIFFORD RILEY.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Singapore | 2 | |
#3 | Taiwan | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | Chile | 1 | |
#8 | China | 1 | |
#9 | Dominican Republic | 1 | |
#10 | EPO (European Patent Office) | 1 | |
#11 | Israel | 1 | |
#12 | Japan | 1 | |
#13 | Republic of Korea | 1 | |
#14 | Mexico | 1 | |
#15 | Peru | 1 | |
#16 | Philippines | 1 | |
#17 | Tunisia | 1 | |
#18 | Ukraine | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Yeager James L | 20 |
#2 | Paridon Stephen M | 5 |
#3 | Goldberg David J | 5 |
#4 | James L Yeager | 4 |
#5 | Goldberg David | 1 |
#6 | David J Goldberg | 1 |
#7 | Simkin Michele M | 1 |
#8 | Stephen M Paridon | 1 |
#9 | Paridon Stephen | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021061203A1 | Methods of improving exercise performance, single ventricular performance, and myocardial performance index (mpi) in single ventricle heart disease, using udenafil compositions | |
KR20170066334A | Methods of improving myocardial performance in fontan patients using udenafil compositions |